Gupta A K, Pal L S
Department of Medicine, IG Medical College, Shimla.
J Indian Med Assoc. 1998 Apr;96(4):106-8.
Incidence of peptic ulcer is more in people living at higher altitude and similarly relapse of healed duodenal ulcer is more in winter season. Seasonal behaviour of healed duodenal ulcer with or without maintenance therapy with H2 blockers was studied among subjects residing around Shimla (approximate altitude 7000 feet above mean sea level). Sixty-four subjects of endoscopically healed duodenal ulcer were alternatively advised placebo (32 subjects) and ranitidine 150 mg (32 subjects) at bed time as maintenance therapy for period of one year. Subjects were reviewed endoscopically and evaluated for H pylori by rapid urease test, every months or earlier if symptomatic. Relapse rate was analysed among 60 subjects at the end of one year. Cumulative relapse rate was found 60% in ranitidine group and 100% in placebo group. In ranitidine group percentage of relapse to number of endoscopic examinations was 21.4% throughout the year, but in placebo group during winter and spring season relapse was 87.5% of endoscopic examination whereas 57.2% during summer and fall season. Incidence of duodenal ulcer relapse without maintenance therapy was more in winter and spring season (October to March) as compared to summer and fall (April to September), whereas intermittent seasonal treatment is efficacious in prevention of duodenal ulcer relapse and also improves cost benefit ratio of ulcer treatment.
消化性溃疡的发病率在居住于高海拔地区的人群中更高,同样地,愈合后的十二指肠溃疡在冬季更容易复发。在西姆拉(海拔约高于平均海平面7000英尺)周边居住的人群中,研究了愈合后的十二指肠溃疡在接受或未接受H2受体阻滞剂维持治疗情况下的季节性表现。64例经内镜检查十二指肠溃疡已愈合的受试者被交替给予安慰剂(32例受试者)和雷尼替丁150毫克(32例受试者),于睡前服用作为维持治疗,为期一年。每月或在出现症状时更早进行内镜复查,并通过快速尿素酶试验评估幽门螺杆菌情况。在一年结束时对60例受试者的复发率进行分析。结果发现雷尼替丁组的累积复发率为60%,安慰剂组为100%。雷尼替丁组全年复发率与内镜检查次数的百分比为21.4%,但安慰剂组在冬季和春季复发率占内镜检查的87.5%,而在夏季和秋季为57.2%。与夏季和秋季(4月至9月)相比,未进行维持治疗时十二指肠溃疡在冬季和春季(10月至3月)的复发率更高,而间歇性季节性治疗在预防十二指肠溃疡复发方面有效,且还能提高溃疡治疗的成本效益比。